Impact of Glucocorticoids on Cardiovascular System—The Yin Yang Effect

Abstract

Glucocorticoids are not only endogenous hormones but are also administered exogenously as an anti-inflammatory and immunosuppressant for their long-term beneficial and lifesaving effects. Because of their potent anti-inflammatory property and ability to curb the cytokines, they are administered as lifesaving steroids. This property is not only made use of in the cardiovascular system but also in other major organ systems and networks. There is a fine line between their use as a protective anti-inflammatory and a steroid that could cause overuse-induced complications in major organ systems including the cardiovascular system. Studies conducted in the cardiovascular system demonstrate that glucocorticoids are required for growth and development and also for offering protection against inflammatory signals. Excess or long-term glucocorticoid administration could alter cardiac metabolism and health. The endogenous dysregulated state due to excess endogenous glucocorticoid release from the adrenals as seen with Cushing’s syndrome or excess exogenous glucocorticoid administration leading to Cushing’s-like condition show a similar impact on the cardiovascular system. This review highlights the importance of maintaining a glucocorticoid balance whether it is endogenous and exogenous in regulating cardiovascular health.

TNFSF13B rs9514828 C>T Polymorphism is Associated with Incidence of Atherosclerosis and Therapeutic Outcomes in Patients with Systemic Lupus Erythematosus

“… 61 Additionally, the genetic marker could also predispose an individual to the risk of atherosclerosis especially genes that are related to the immune response such as TNFSF13B . 62 , 63 The TNFSF13B gene encodes the BAFF protein, which plays a critical role in B-cell modulation. The increase in serum BAFF levels is higher in individuals at risk of atherosclerosis compared to those who are not at risk.…”

Autoimmune and Non-Autoimmune Comorbidities in Myasthenic Patients of East-European Descent: A Case–Control Study

“…On the other side, one must not omit the fact that some of our chronic patients' comorbidities and elevated GLR may be involved in a cause-effect relationship with the specific anti-myasthenic treatments. Specifically, mainly the chronic administration of corticosteroids is a probable factor as it is a known fact that doses higher than 7.5 mg/day of prednisone or equivalent doses of prednisone are associated with cardiovascular risks and, to a lesser extent, mood disorders [31,42]. Moreover, corticosteroids have been acknowledged to induce metabolic and hematological side effects such as an increase in plasma glucose and circulating polymorphonuclear levels, while the levels of the other granulocytes, lymphocytes and monocytes, decrease mainly by the redistribution of these cells [43].…”

Clinical courses and predictors of left ventricular systolic dysfunction in systemic sclerosis: A cohort study

“…The enzyme is also expressed in endothelial cells, where it causes vascular hypertrophy and fibrosis. [ 35 ] In a cohort study, Wei et al . discovered that patients receiving high-dose exogenous steroids equivalent to prednisolone ≥ 7.5 mg/d had a 2.5-fold increased risk for cardiovascular events compared to those who received low-dose steroids.…”